유기합성 분자공학 연구실

In the field of catalysis, our research focuses on the development of heterogeneous catalysts as effective tools for fine chemicals and pharmaceuticals. We investigate organic transformations on heterogeneous catalysts with a strong emphasis on sustainability. Heterogeneous catalysis has played a vital role in industrial chemical production due to its robustness, lower operational costs, and the ease of catalyst recovery and separation. With over 90% of chemical processes utilizing catalysts, the development and design of active and stable heterogeneous catalysts have become important and actively studied. Our specific interest lies in developing synthetic chemical protocols that utilize heterogeneous catalytic systems, with a particular focus on tandem reactions and photocatalysis for the production of fine chemicals and pharmaceuticals. In the field of drug discovery, we concentrate on the development of small molecule drugs that can selectively inhibit or remove disease-causing proteins. Small molecule drugs possess distinct advantages as therapeutics and can be rationally designed to target various biological proteins, making them a cornerstone of the pharmaceutical industry for nearly a century. Our research involves the design and synthesis of small molecules that exhibit selectivity in inhibiting or removing disease-causing proteins in cellular and animal models. The rational design of these molecules requires a broad range of techniques, including target protein analysis and molecular modeling. We have extensive experience in studying and developing a variety of small molecule candidates using these techniques. Currently, we are engaged in several collaborative research projects with biologists and medical doctors at our institution.